Beam Therapeutics (NASDAQ:BEAM) Announces Earnings Results
Beam Therapeutics (NASDAQ:BEAM – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported $1.73 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.69) by $2.42, Briefing.com reports. The company had revenue of $316.20 million for the quarter, compared to analysts’ expectations of $34.16 million. Beam Therapeutics had […]